Biomarker shows potential for early diagnosis of lung cancer

A collaboration between physicians and scientists at UNC Lineberger Comprehensive Cancer Center and the University of Texas M.D. Anderson Cancer Center has demonstrated that a biomarker called TCF21 may be used to develop a potential screening test for early-stage lung cancer.

Read the whole article on Physorg

More from Physorg